Categories: The Charlton Centre

Charlton Infusion Clinics Continue to Provide Care

Charlton Health is very proud of our team as they continue to offer excellent care during this difficult time.  As we are very aware of the importance of maintaining treatment for autoimmune diseases, we are making every effort to ensure your treatment continues with the highest measures of  safety.   All infusion clinics are screening every patient before they come for an infusion to be sure they have no symptoms, have not been in contact with a positive case of COVID-19, or a quarantined person and have not travelled outside of Canada in the last 14 days.  Each clinic fully cleans all surfaces before and after each patient and is positioning patients to maintain an appropriate distancing.  A person on treatment in a state of low disease activity, has less infection risk than a flared untreated person.

Our advice is:

  • Maintain treatment
  • Practice excellent hand washing
  • Don’t touch your face
  • Maintain physical distancing
  • Continue with your medical treatment and appointments when appropriate, and other than that: STAY HOME!
admin

Recent Posts

Bimzelx Now Approved for Hidradenitis Suppurativa (HS)

Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition that can be very painful and…

4 days ago

Happy Holidays from Charlton Health

As the year comes to a close, we wish you a joyful holiday season filled…

3 weeks ago

Winrevair: A New Treatment Option for Pulmonary Arterial Hypertension (PAH)

Pulmonary arterial hypertension occurs when there is increased pressure in the small blood vessels that…

1 month ago

New Biologic Treatment for PMR (Polymyalgia Rheumatica)

Polymyalgia rheumatica (PMR) is an inflammatory condition that causes widespread joint and muscle pain along…

2 months ago

Expanded Protection: RSV Vaccine Now Approved for More Adults

Respiratory Syncytial Virus (RSV) is a common virus that can cause serious lung infections, particularly in…

2 months ago

Rinvoq: A New Oral Option for Giant Cell Arteritis

Health Canada has recently approved Rinvoq (upadacitinib) for adults living with Giant Cell Arteritis (GCA). Rinvoq…

3 months ago